Display measures
Measures CMS publishes alongside the Star Ratings but doesn't score: new measures being tested before they count, measures retired from the Star Ratings, and operational ones such as call-center hold times and grievance rates. Published with the 2026 Star Ratings; most measure 2024. CMS posts each year's display measures a few weeks after the ratings.
How to read this
National average: CMS's published average for MA contracts (and for stand-alone drug plans where CMS gives one), from the Display Measures Technical Notes. Better: which direction is good; display measures have no stars, so this site sets it from what each measure counts (a lower grievance rate, a higher screening rate). Two measures have no better direction: Plan Finder price stability, where 100% means prices held steady, and plans' submitted prices.
A measure followed across years is matched by name, because CMS renumbers display measures most years. Hold times are minutes:seconds.
Customer service and complaints
| Measure | National averageMA · drug plans | Prior yearMA | Better | Contracts reporting | Years published |
|---|---|---|---|---|---|
| Call Center – Beneficiary Hold Time (health plan)DMC04 | 0:32 | 0:37 | Lower | 703 | 11since 2016 |
| Call Center - Calls Disconnected When Customer Calls Health PlanDMC07 | 1% | 1.4% | Lower | 703 | 11since 2016 |
| Call Center - Calls Disconnected When Customer Calls Drug PlanDMD01 | 0.9%0.8% | 1.4% | Lower | 721 | 11since 2016 |
| Call Center – Beneficiary Hold Time (drug plan)DMD02 | 0:300:36 | 0:35 | Lower | 721 | 11since 2016 |
| Call Center – Pharmacy Hold TimeDMD04 | 0:200:17 | 0:27 | Lower | 721 | 11since 2016 |
| Grievance RateDME01 | 7.211.54 | 6.73 | Lower | 578 | 12since 2015 |
| Beneficiary Access and Performance ProblemsDME07 | 9495 | 90 | Higher | 749 | 9since 2015 |
Why members leave
| Measure | National averageMA · drug plans | Prior yearMA | Better | Contracts reporting | Years published |
|---|---|---|---|---|---|
| Disenrollment Reasons - Problems Getting the Plan to Provide and Pay for Needed Care (MA-PD, MA-only)DME02 | 15% | 17% | Lower | 302 | 6since 2021 |
| Disenrollment Reasons - Problems with Coverage of Doctors and Hospitals (MA-PD, MA-only)DME03 | 23% | 23% | Lower | 351 | 12since 2015 |
| Disenrollment Reasons - Financial Reasons for Disenrollment (MA-PD, MA-only, PDP)DME04 | 19%53% | 19% | Lower | 371 | 12since 2015 |
| Disenrollment Reasons - Problems with Prescription Drug Benefits and Coverage (MA-PD, PDP)DME05 | 8%9% | 8% | Lower | 118 | 12since 2015 |
| Disenrollment Reasons - Problems Getting Information and Help from the Plan (MA-PD, PDP)DME06 | 11%6% | 12% | Lower | 336 | 8since 2019 |
Hospital stays and care transitions
| Measure | National averageMA · drug plans | Prior yearMA | Better | Contracts reporting | Years published |
|---|---|---|---|---|---|
| Follow-up Visit after Hospital Stay for Mental Illness (within 30 days of discharge)DMC01 | 51% | 50% | Higher | 363 | 12since 2015 |
| Hospitalization for Potentially Preventable ComplicationsDMC13 | 37% | 18% | Lower | 552 | 10since 2017 |
| Transitions of Care - Medication Reconciliation Post-DischargeDMC14 | 77% | 72% | Higher | 587 | 7since 2020 |
| Transitions of Care - Notification of Inpatient AdmissionDMC15 | 52% | 45% | Higher | 584 | 7since 2020 |
| Transitions of Care - Patient Engagement After Inpatient DischargeDMC16 | 88% | 86% | Higher | 587 | 7since 2020 |
| Transitions of Care - Receipt of Discharge InformationDMC17 | 34% | 29% | Higher | 584 | 7since 2020 |
Prevention and chronic care
Member experience and functioning
| Measure | National averageMA · drug plans | Prior yearMA | Better | Contracts reporting | Years published |
|---|---|---|---|---|---|
| Doctors who Communicate WellDMC03 | 93% | 93% | Higher | 315 | 12since 2015 |
| Access to Primary Care Doctor VisitsDMC06 | 95% | 95% | Higher | 621 | 12since 2015 |
| Physical Functioning Activities of Daily LivingDMC18 | 94% | 94% | Higher | 493 | 6since 2021 |
| Care of Older Adults - Functional StatusDMC19 | 84% | 80% | Higher | 344 | 5since 2022 |
Prescriptions and drug plan
| Measure | National averageMA · drug plans | Prior yearMA | Better | Contracts reporting | Years published |
|---|---|---|---|---|---|
| MPF – StabilityDMD03 | 100%100% | 100% | — | 649 | 12since 2015 |
| Plan Submitted Higher Prices for Display on MPFDMD05 | 5756 | 74 | — | 693 | 12since 2015 |
| Reminders to Fill PrescriptionsDMD06 | 55%53% | 55% | Higher | 574 | 12since 2015 |
| Reminders to Take MedicationsDMD07 | 35%27% | 34% | Higher | 576 | 12since 2015 |
| Persistence to Basal Insulin (PST-INS)DMD16 | 70%69% | 70% | Higher | 651 | 3since 2024 |
| Medication Adherence for Diabetes Medications Measure with Risk Adjustment (RA)DMD17 | 87%86% | — | Higher | 694 | 1since 2026 |
| Medication Adherence for Hypertension (RAS Antagonists) Measure with RA (ADH-RAS RA)DMD18 | 90%88% | — | Higher | 708 | 1since 2026 |
| Medication Adherence for Cholesterol (Statins) Measure with RA (ADH-Statins RA)DMD19 | 88%87% | — | Higher | 712 | 1since 2026 |
Drug safety
| Measure | National averageMA · drug plans | Prior yearMA | Better | Contracts reporting | Years published |
|---|---|---|---|---|---|
| Antipsychotic Use in Persons with DementiaDMD08 | 8%9% | 7% | Lower | 652 | 9since 2018 |
| Antipsychotic Use in Persons with Dementia - for Long-Term Nursing Home ResidentsDMD09 | — | 7% | Lower | 398 | 8since 2019 |
| Concurrent Use of Opioids and BenzodiazepinesDMD10 | 13%14% | 14% | Lower | 655 | 6since 2021 |
| Use of Opioids at High Dosage in Persons Without CancerDMD11 | 5%5% | 6% | Lower | 657 | 6since 2021 |
| Use of Opioids from Multiple Providers in Persons Without CancerDMD12 | 0.3%0.2% | — | Lower | 657 | 6since 2021 |
| Polypharmacy: Use of Multiple Anticholinergic Medications in Older AdultsDMD13 | 9%7% | 9% | Lower | 659 | 6since 2021 |
| Polypharmacy: Use of Multiple CNS-Active Medications in Older AdultsDMD14 | 13%10% | 13% | Lower | 689 | 6since 2021 |
| Initial Opioid Prescribing (IOP-LD)DMD15 | 17%12% | 17% | Lower | 680 | 4since 2023 |